DDX20 and esophageal adenocarcinoma: DDX20 rs197412 T variant was also found consistently associated with overall survival in patients with RCC [29] and non-Hodgkin’s lymphoma (NHL) [16], recurrence-free survival in bladder cancer [35], and both overall survival and progression-free survival in patients with esophageal adenocarcinoma [30].